Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 949, pseudogene (RNU6-949P) is a processed pseudogene of the U6 small nuclear RNA gene family found in the human genome[4][5]. U6 snRNA is an essential component of the spliceosome and catalyzes pre-mRNA splicing, but RNU6-949P itself does not produce functional RNA or protein and is regarded as a non-coding, nonfunctional genomic element[1][4][5]. Pseudogenes such as RNU6-949P are typically considered transcriptionally inactive; however, in some cases, pseudogene transcripts can exert regulatory roles through RNA-mediated mechanisms (e.g., functioning as miRNA decoys or producing regulatory lncRNAs), although such functions have not been demonstrated for RNU6-949P[2]. There are no data implicating RNU6-949P in any disease, nor is it used as a biomarker or drug target at present[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 949, pseudogene (RNU6-949P).